PRL PTPs: mediators and markers of cancer progression
- 26 January 2008
- journal article
- review article
- Published by Springer Science and Business Media LLC in Cancer and Metastasis Reviews
- Vol. 27 (2), 231-252
- https://doi.org/10.1007/s10555-008-9121-3
Abstract
Aberrant protein tyrosine phosphorylation resulting from the altered activity of protein tyrosine phosphatases (PTPs) is increasingly being implicated in the genesis and progression of human cancer. Accumulating evidence indicates that the dysregulated expression of members of the phosphatase of regenerating liver (PRL) subgroup of PTPs is linked to these processes. Enhanced expression of the PRLs, notably PRL-1 and PRL-3, promotes the acquisition of cellular properties that confer tumorigenic and metastatic abilities. Up-regulation of PRL-3 is associated with the progression and eventual metastasis of several types of human cancer. Indeed, PRL-3 shows promise as a biomarker and prognostic indicator in colorectal, breast, and gastric cancers. However, the substrates and molecular mechanisms of action of the PRLs have remained elusive. Recent findings indicate that PRLs may function in regulating cell adhesion structures to effect epithelial-mesenchymal transition. The identification of PRL substrates is key to understanding their roles in cancer progression and exploiting their potential as exciting new therapeutic targets for cancer treatment.Keywords
This publication has 104 references indexed in Scilit:
- Restoring E-cadherin-mediated cell–cell adhesion increases PTEN protein level and stability in human breast carcinoma cellsBiochemical and Biophysical Research Communications, 2007
- Oxidative stress-induced expression and modulation of Phosphatase of Regenerating Liver-1 (PRL-1) in mammalian retinaBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2007
- High PRL-3 expression in human gastric cancer is a marker of metastasis and grades of malignancies: an in situ hybridization studyVirchows Archiv, 2007
- Expression and prognostic impact of the protein tyrosine phosphatases PRL-1, PRL-2, and PRL-3 in breast cancerBritish Journal of Cancer, 2006
- Identification of integrin α1 as an interacting protein of protein tyrosine phosphatase PRL-3Biochemical and Biophysical Research Communications, 2006
- Complex networks orchestrate epithelial–mesenchymal transitionsNature Reviews Molecular Cell Biology, 2006
- Perturbations of the AKT signaling pathway in human cancerOncogene, 2005
- Identification of a Novel β-Catenin-Interacting ProteinBiochemical and Biophysical Research Communications, 2000
- Mouse PRL-2 and PRL-3, Two Potentially Prenylated Protein Tyrosine Phosphatases Homologous to PRL-1Biochemical and Biophysical Research Communications, 1998
- Protein-Tyrosine Phosphatases: Biological Function, Structural Characteristics, and Mechanism of CatalysisCritical Reviews in Biochemistry and Molecular Biology, 1998